Sysmex
Sysmex Inostics Gets NYS CLEP Approval for Clinical Trial Use of Liquid Biopsy Assay
The Baltimore-based subsidiary of Japan's Sysmex said that the test is used to identify genetic mutations that are relevant for the treatment of various cancer types.
Sysmex, Qiagen Expand Strategic Partnership
The firms will collaborate in the area of genetic testing and use a Qiagen-developed assay to support clinical trials at Sysmex's global laboratory network.
People in the News at Mission Bio, Seer, Sysmex, SMi Systems, Next Gen Diagnostics
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Sysmex Gets Approval in Japan for Retinal Dystrophy Gene Panel
The next-generation sequencing panel identifies genetic mutations that cause inherited retinal dystrophy, which results in vision problems, including blindness.
Juntendo University, Sysmex, and ThinkCyte Collaborating on Tests, Treatments for CML
The parties will use ThinkCyte's Ghost Cytometry technology to develop better diagnostics for early detection of blood cancers and advance treatment of CML.